PRESTIGE BIOPHARMA 프레스티지바이오파마 Prestigebiopharma

Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 76

Number	Thumbnail	Title	Author	Date	Votes	Views
76		Prestige Biopharma Receives Brazilian Marketing Authorization for Herceptin Biosimilar Tuznue 김** \| 2026.09.28 \| Votes 0 \| Views 189	김**	2026.09.28	0	189
75		Prestige Biopharma’s Tuznue Receives Marketing Authorization in Trinidad and Tobago 김** \| 2026.09.18 \| Votes 0 \| Views 582	김**	2026.09.18	0	582
74		Prestige Biopharma IDC Obtains ISO 14001 and ISO 45001 Certifications 김** \| 2026.09.17 \| Votes 0 \| Views 384	김**	2026.09.17	0	384
73		Prestige Biopharma Successfully Concludes ‘Prestige Symposium’ on Aging 김** \| 2026.09.09 \| Votes 0 \| Views 977	김**	2026.09.09	0	977
72		Prestige Biopharma IDC CEO Ko Sang-seok Purchases Company Shares on the Open Market 김** \| 2026.09.03 \| Votes 0 \| Views 1170	김**	2026.09.03	0	1170
71		Prestige Biopharma’s Tuznue Secures Brazilian GMP Certification, Supporting Latin American Approval Process 김** \| 2026.08.25 \| Votes 0 \| Views 1861	김**	2026.08.25	0	1861
70		Prestige Biopharma Files Patent Application for TASA™, a Blood-Based Pancreatic Cancer Diagnostic Platform 김** \| 2026.08.12 \| Votes 0 \| Views 1899	김**	2026.08.12	0	1899
69		Prestige Biopharma Positions PBP1710 as Its Next-Generation Growth Driver 김** \| 2026.08.11 \| Votes 0 \| Views 2398	김**	2026.08.11	0	2398
68		Prestige Biopharma CEO Soyeon Park Purchases Approximately 70,000 Additional Shares, Bringing Total Purchases to 161,765 Shares 김** \| 2026.08.04 \| Votes 0 \| Views 2320	김**	2026.08.04	0	2320
67		Prestige Biopharma IDC Publishes Preclinical Efficacy Results of IDC007 in International Academic Journal 김** \| 2026.07.16 \| Votes 0 \| Views 3430	김**	2026.07.16	0	3430

Read Prestige news >>